⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDVA News
Endovia Health Sciences, Inc.
Form 8-K
sec.gov
EDVA
Form 8-K
sec.gov
EDVA
Form 8-K
sec.gov
EDVA
Form 8-K
sec.gov
OSTX
PTHS
EDVA
BLNE
Form 8-K
sec.gov
EDVA
Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
globenewswire.com
EDVA
Form 8-K
sec.gov
EDVA
Form 8-K
sec.gov
EDVA
Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways
globenewswire.com
EDVA
Form 8-K
sec.gov
EDVA
SBEV